SK
Shiv Kumar Issar
About Shiv Kumar Issar
Data last updated:
Shiv Kumar Issar is a Director at Clinirx Research Private Limited (since 2019) and Director at Bhuvas Elements Private Limited (since 2023). The companies operate in Life Sciences and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹73.81 Cr; the largest is Clinirx Research Private Limited at ₹72.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clinirx Research Private Limited U85110WB2004PTC098498 | Director | 20 May 2019 | 2004 | ₹72.45 Cr (FY 2025) | Active |
| Bhuvas Elements Private Limited U01100DL2022PTC398855 | Director | 20 Dec 2023 | 2022 | ₹1.36 Cr (FY 2025) | Active |
Board colleagues of Shiv Kumar Issar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nayantika | Clinirx Research Private Limited | Company Secretary | |
| Pawan Kumar Rustagi | 00006979 | Clinirx Research Private Limited | Director |
| Sujit Kumar Mukherjee | 00271301 | Clinirx Research Private Limited | Director |
| Sunil Chawla | 09616147 | Bhuvas Elements Private Limited | Director |
| Swati Singhania | 00095409 | Bhuvas Elements Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shiv Kumar Issar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shiv Kumar Issar
Shiv Kumar Issar currently holds 2 directorships: Clinirx Research Private Limited (Director, since 20 May 2019, revenue ₹72.45 Cr (FY 2025)); Bhuvas Elements Private Limited (Director, since 20 Dec 2023, revenue ₹1.36 Cr (FY 2025)).
Shiv Kumar Issar was first appointed on 20 May 2019 as Director at Clinirx Research Private Limited. The most recent appointment on record is 20 Dec 2023 at Bhuvas Elements Private Limited.
The 2 current companies of Shiv Kumar Issar that report revenue have a combined latest revenue of ₹73.81 Cr: Clinirx Research Private Limited ₹72.45 Cr (FY 2025); Bhuvas Elements Private Limited ₹1.36 Cr (FY 2025).
The current boards of Shiv Kumar Issar's companies include Nayantika (Clinirx Research Private Limited), Pawan Kumar Rustagi (Clinirx Research Private Limited), Sujit Kumar Mukherjee (Clinirx Research Private Limited), Sunil Chawla (Bhuvas Elements Private Limited), Swati Singhania (Bhuvas Elements Private Limited).